Place of Semisynthetic Penicillins and Macrolides in Antibiotic Therapy for Respiratory Infections in Children

A.Ye. Abaturov, O.N. Gerasimenko

Abstract


The paper presents an overview of the guidelines for the treatment of respiratory infections by the Pediatric Infectious Diseases Society and Infectious Diseases Society of America (2011), the British Thoracic Society (2013) and national ones (Protocol for providing medical care to children in «pediatric pulmonology» specialty, 2005). An algorithm for the empirical antibiotic choice in the treatment of acute respiratory infections in children, depending on the etiology and age is considered. It is shown that amoxicillin is still the agent of choice in pediatric outpatient practice for the treatment of acute bacterial respiratory infections. Alternative therapy — oral amoxicillin clavulanate; in children with allergy to amoxicillin — macrolides. Macrolide antibiotics (oral form) should be prescribed for the treatment of children (primarily schoolchildren and adolescents) with acute respiratory infection caused by atypical pathogens. When choosing a drug, dispersible forms of antibiotics should be preferred: Flemoxin Solutab® (amoxicillin trihydrate), Flemoclav Solutab® (amoxicillin trihydrate + clavulanic acid), Wilprafen® Solutab (josamycin).

Keywords


аcute respiratory infection; antibiotics; dispersible form; children.

References


Абатуров А.Е. Значение бактериальных лизатов в профилактике острых респираторных инфекций у детей // Здоровье ребенка. — 2013. — № 5(48). — С. 83-88.

Лечение внебольничных пневмоний у детей старше 3 месяцев. Рекомендации Общества педиатрических инфекций и Общества инфекционистов Америки // Болезни и антибиотики. — 2011. — № 2 (05) [Електронний ресурс]. — Режим доступу: http://www.mif-ua.com/archive/article/24910

Наказ МОЗ України № 18 від 13.01.2005 «Про затвердження Протоколів надання медичної допомоги дітям за спеціальністю «дитяча пульмонологія» [Електронний ресурс]. — Режим доступу: http://mozdocs.kiev.ua/view.php?id=3658

Юлиш Е.И. Макролиды в лечении заболеваний органов дыхания у детей, вызванных вне- и внутриклеточными микроорганизмами //Здоровье ребенка. — 2014. — № 4 (55). — С. 63-67.

Юлиш Е.И. Диспергируемая лекарственная форма амоксициллина в лечении нетяжелых внебольничных пневмоний у детей / Юлиш Е.И., Балычевцева И.В., Гадецкая С.Г. // Здоровье ребенка. — 2013. — № 2. — С. 59-62.

Bowen S.-J.M., Thomson A.H. British Thoracic Society Paediatric Pneumonia Audit: a review of 3 years of data //Thorax. — 2013. — 68. — 682-683. doi:10.1136/thoraxjnl-2012-203026.

Queen M.A., Myers A.L., Hall M. et al. Comparative Effectiveness of Empiric Antibiotics for Community-Acquired Pneumonia // Pediatrics. — 2014. — 133(1). — e23-9. doi: 10.1542/peds.2013-1773.

Hersh A.L., Jackson M.A., Hicks L.A. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. American Academy of Pediatrics Committee on Infectious Diseases // Pediatrics. — 2013. — 132(6). — 1146-54. doi: 10.1542/peds.2013-3260.

The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America / J.S. Bradley, C.L. Byington, S.S. Shah, B. Alverson [et al]. Pediatric Infectious Diseases Society and the Infectious Diseases Society of America // Clin. Infect. Dis. — 2011 Oct. — 53(7). — e25-76. doi: 10.1093/cid/cir531.

WHO Model List of Essential Medicines for Children 3rd list (March 2011). — Режим доступа: http://whqlibdoc.who.int/hq/2011/a95054_eng.pdf?ua=1




DOI: https://doi.org/10.22141/2224-0551.6.57.2014.75726

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru